News

Pfizer opens facility to advance gene therapy for hemophilia in Sanford, North Carolina

In August 2017, Pfizer committed to building a $100 million gene therapies plant in North Carolina and, in exchange, North Carolina committed to providing the drugmaker with a quarter-million dollars' worth of help. Pfizer will expand an 11,000-square-foot plant in Sanford, North Carolina that it acquired last year when it bought gene therapies biotech Bamboo Therapeutics in a deal valued at up to $688 million. Bamboo bought the facility last year from the University of North Carolina about the time that Pfizer made its initial investment in the company.

Pfizer opens facility to advance gene therapy for hemophilia in Sanford, North Carolina - Read More…

NC Congressman David E. Price to Receive Award from Cure HHT

Cure HHT to Present Congressman David E. Price with its "Champion Award" at Launch of Multi-State Pilot Program Headquartered at UNC Chapel Hill

NC Congressman David E. Price to Receive Award from Cure HHT - Read More…

UNC-Chapel Hill physical therapist Jennifer Newman to moderate and speak at sessions during NHF meeting

UNC Hemophilia Treatment Center physical therapist Jennifer Newman, PT, MSPT, will moderate and speak at sessions on August 24, 2017 and August 25, 2017 at the National Hemophilia Foundation annual meeting in Chicago.

UNC-Chapel Hill physical therapist Jennifer Newman to moderate and speak at sessions during NHF meeting - Read More…

UNC researchers present at the 12th HHT International Scientific Conference

The HHT International Scientific Conference is held every other year. It is the premier conference on HHT, and over 250 basic and clinical researchers from around the world attend and present their work. The 12th HHT International Scientific Conference was held from June 8-11, 2017 in Dubrovnik.

UNC researchers present at the 12th HHT International Scientific Conference - Read More…

Registration for the 9th Symposium on Hemostasis now open

The 9th Symposium on Hemostasis, "Advances in the Clinical and Basic Sciences of Coagulation," will be held April 12-14, 2018, in Chapel Hill, North Carolina.

Registration for the 9th Symposium on Hemostasis now open - Read More…

Earl W. Davie Symposium features UNC Professor Nigel Key, MD as keynote speaker

Dr. Nigel Key, Professor of Medicine and Pathology, Chief of the Section of Classical Hematology, and the Director of the UNC Hemophilia and Thrombosis Center, was a keynote speaker at the annual Earl W. Davie Symposium in Vancouver, BC on November 17, 2016.

Earl W. Davie Symposium features UNC Professor Nigel Key, MD as keynote speaker - Read More…

UNC physician Yasmina Abajas, MD, receives NHF-Baxalta Clinical Fellowship

Dr. Abajas received a two-year award (July 1, 2016 - June 30, 2018) to support clinical and research training in bleeding and clotting disorders.

UNC physician Yasmina Abajas, MD, receives NHF-Baxalta Clinical Fellowship - Read More…

ISTH Advanced Training Course in Thrombosis and Hemostasis to be held November 1-4, 2016

The International Society on Thrombosis and Hemostasis will hold its Advanced Training Course in Thrombosis and Hemostasis in Atlanta, Georgia, November 1-4, 2016. UNC Hemophilia and Thrombosis Center Director Nigel Key, M.D., is chairing and speaking, and UNC physician Stephan Moll, M.D., is speaking as well.

ISTH Advanced Training Course in Thrombosis and Hemostasis to be held November 1-4, 2016 - Read More…

"Endeavors" publishes article charting UNC-Chapel Hill's long involvement in bleeding disorders research and treatment

"Endeavors" magazine, which writes about research and creative activity at UNC-Chapel Hill, published an article in its July issue about UNC-Chapel Hill's history of research and treatment for blood disorders, which began in 1947 under Dr. Kenneth Brinkhous. His seminal work set the stage for major breakthroughs in hemophilia and HIV.

"Endeavors" publishes article charting UNC-Chapel Hill's long involvement in bleeding disorders research and treatment - Read More…

FDA approves Bayer AG's Kovaltry for hemophilia A

Kovaltry is designed to reduce bleeding in patients with hemophilia A when infused prophylactically two or three times per week, and was approved by the European Commission on Feb. 22.

FDA approves Bayer AG's Kovaltry for hemophilia A - Read More…

Local man with hemophilia featured on WTVD

George McCoy, a longtime patient at the UNC Hemophilia & Thrombosis Center and the first man in the world to receive recombinant clotting factor, was the subject of a news story on WTVD on February 16.

Local man with hemophilia featured on WTVD - Read More…

UNC's 340B Pharmacy Receives Accreditation as a Specialty Pharmacy from URAC

UNC's 340B pharmacy's accreditation by URAC became effective February 1, 2016. URAC's mission is to promote continuous improvement in the quality and efficiency of health care management through processes of accreditation, education, and measurement.

UNC's 340B Pharmacy Receives Accreditation as a Specialty Pharmacy from URAC - Read More…

ISTH Releases New Clinical Core Curriculum on Thrombosis and Hemostasis

In a press release dated January 19, 2016, the International Society on Thrombosis and Haemostasis (ISTH) announced its new international clinical Core Curriculum on thrombosis and hemostasis, the first framework of its kind to define the minimum standards for a medical doctor to attain a level of proficiency to enable them to practice independently as specialists in the field.

ISTH Releases New Clinical Core Curriculum on Thrombosis and Hemostasis - Read More…

Nigel Key, M.D. featured in WebMD article about new treatments for hemophilia

Nigel Key, M.D., Director of the UNC Hemophilia and Thrombosis Center, is extensively quoted in the January 12, 2016 WebMD article "Hemophilia: New Treatments for an Old Disease," by Sonya Collins.

Nigel Key, M.D. featured in WebMD article about new treatments for hemophilia - Read More…

Brenda Nielsen, RN, Named to Advisory Council on Rare Disease

Brenda Nielsen, RN, nurse in the UNC Comprehensive Hemophilia Diagnostic and Treatment Center, will serve a three-year term on this council beginning December 1, 2015 through November 30, 2018.

Brenda Nielsen, RN, Named to Advisory Council on Rare Disease - Read More…

UNC team walks to raise money for 2015 Hemophilia Walk

UNC team walks to raise money for 2015 Hemophilia Walk

On October 17, The UNC TarHealers walk team raised $5,160 for the Raleigh Hemophilia Walk, which benefits Hemophilia of North Carolina and the National Hemophilia Foundation.

UNC team walks to raise money for 2015 Hemophilia Walk - Read More…

Nigel Key, M.D. Gives The Dr. William Bell Lecture in Hematology at Johns Hopkins University

Dr. Key's lecture, which was delivered on Monday, October 19, 2015, was entitled "Thrombosis in Hemolytic Anemias: What are the Common Themes?"

Nigel Key, M.D. Gives The Dr. William Bell Lecture in Hematology at Johns Hopkins University - Read More…